2,5-dihydro-1,2,4-benzothiadiazepine 1,1-dioxides. Synthesis and pharmacological evaluation.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001552:Benzazepines / Q000138:chemical synthesis* / Q000494:pharmacology; D003499:Cyclic S-Oxides / Q000138:chemical synthesis; D006591:Hexobarbital / Q000494:pharmacology; D007259:Infrared Rays; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D012890:Sleep / Q000187:drug effects; D013057:Spectrum Analysis; D013331:Strychnine / Q000037:antagonists & inhibitors; D013454:Sulfoxides / Q000494:pharmacology
D001552:Benzazepines; D003499:Cyclic S-Oxides; D013454:Sulfoxides; D006591:Hexobarbital; D013331:Strychnine; D010433:Pentylenetetrazole